BMO Capital analyst Katja Jancic raised the firm’s price target on Constellium (CSTM) to $30 from $25 and keeps an Outperform rating on the shares after its Q4 earnings beat. Increasing free cash flow generation should support deleveraging and continued share repurchases for the company, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSTM: